Secondary analysis solutions
Streamline and accelerate analysis of genomic data with access to best-in-class tools available to scale on-demand with AWS for Genomics.
AWS HealthOmics Ready2Run Workflows
Transform genomic and biological data into insights
Automate and Accelerate Secondary Analysis
To help genomics organizations optimize workflows and reduce analysis time, AWS for Genomics offers a variety of AWS and AWS Partner workflow automation and secondary analysis solutions and services. Managed services like AWS HealthOmics provide fully managed bioinformatics compute.
Workflow automation
Running genomics workflows requires manual provisioning and configurations. Workflow automation and orchestration tools from AWS, AWS Partners, and the open-source community can help accelerate research and scale compute capabilities. Managed services like AWS HealthOmics provide fully managed bioinformatics compute — simply bring your data, tools, and workflow definition, then run your genomics analyses with just a few clicks.
AWS solutions
Featured customers
Helix
Helix uses BaseSpace Sequence Hub, a genomic data analysis platform from Illumina, to power its work.
Illumina
The DRAGEN Bio-IT platform by Illumina provides accurate, ultra-rapid secondary analysis results. Customers can power and dramatically accelerate their analyses with DRAGEN running on Amazon EC2 F1 instances.
Featured partner solutions
DNAnexus
"Top diagnostics and biopharma companies leverage DNAnexus on AWS to automate recurrent data intensive tasks for speed and accuracy. As a result, these companies achieve dramatic reduction in their R&D, speeding up pipeline development from weeks to hours."
Seqera Labs
"Seqera Labs and AWS have collaborated to ensure that AWS is the environment of choice for life science workloads. Nextflow and Nextflow Tower are seamlessly integrated into AWS Batch for elastic compute, EKS for seamless deployment, and AWS file and object storage services for cost-effective and performant data storage." Seven Bridges
"The Seven Bridges platform and Seven Bridges analysis tools such as GRAF™ and ARIA™ rely on the flexibility and scalability of AWS to enable researchers to take advantage of massive repositories of genomic and phenotypic data — which have the potential to reveal transformative insights into the underpinnings of disease, novel therapeutic approaches and in silico disease models." Illumina
"Accuracy and speed are essential to unlocking the power of the human genome. The DRAGEN Bio-IT platform by Illumina, provides accurate, ultra-rapid secondary analysis results. Customers can power and dramatically accelerate their analyses with DRAGEN running on AWS. "
NVIDIA
"NVIDIA Clara Parabricks Pipelines is a GPU-accelerated compute framework, supporting genomic applications that span DNA to RNA. The acceleration of Parabricks coupled to the scalability of AWS is powering the genomics industry to perform projects faster, more cost effectively, and letting researchers identify more genetic variants in their data."
Featured consulting partners
AWS Marketplace
The DRAGEN Bio-IT Platform by Illumina enables ultra-rapid analysis of Next Generation Sequencing (NGS) data for large data sets, such as whole genomes, exomes, and genes/panels. The analysis includes mapping, aligning, sorting, duplicate marking, small variant calling, and more.
Secondary analysis
As adoption of genomics continues to accelerate, secondary analysis is often cited as a constraint. To accelerate analysis and keep pace with increasing demand, genomics organizations leverage the scalability and cost efficiency of AWS.
Featured resource
Optimizing Secondary Analysis Compute Costs
Learn how to optimize secondary analysis compute costs using Amazon Elastic Compute Cloud (EC2), spot instances, and AWS Batch. Read white paper